
APNIMED INC
APMD · NASDAQ
Updated at 2026-10-19 00:31:18
- Today's High
- $18.35
- Today’s Low
- $17.39
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $18.30
- Previous Close
- $17.76
- Volume
- 235.05K
- Market Cap
- $739.36M
- P/E Ratio
- --
- EPS
- --
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 39 JOHN F. KENNEDY STREET, CAMBRIDGE, MA, UNITED STATES, 02138
- Country
- US
- Listing Date
- 2026-07-31
- Fiscal Year End
- December
- Shares Outstanding
- 0
- CIK
- --
- Website
- apnimed.com
Apnimed, Inc. is a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. The company is headquartered in Cambridge, Massachusetts.
Financial Metrics
Revenue
2026-06-30
$12.08M
2026-03-31
$84.81M
2025-06-30
$17.11M
2025-03-31
$3.13M
Operating Expenses
2026-06-30
$23.78M
2026-03-31
$16.77M
2025-06-30
$23.04M
2025-03-31
$30.24M
Net Income
2026-06-30
$125.93M
2026-03-31
$70.37M
2025-06-30
-$69.47M
2025-03-31
-$28.64M
Net Profit Margin
2026-06-30
1.04K%
2026-03-31
82.97%
2025-06-30
-406.04%
2025-03-31
-914.91%
Earnings Per Share
2026-06-30
$0.51
2026-03-31
--
2025-06-30
--
2025-03-31
--
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$11.69M
2026-03-31
$68.05M
2025-06-30
-$5.93M
2025-03-31
-$27.1M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-06-30
--
2025-03-31
--
| Item | 2026-06-30 | 2026-03-31 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Revenue | $12.08M | $84.81M | $17.11M | $3.13M |
| Operating Expenses | $23.78M | $16.77M | $23.04M | $30.24M |
| Net Income | $125.93M | $70.37M | -$69.47M | -$28.64M |
| Net Profit Margin | 1.04K% | 82.97% | -406.04% | -914.91% |
| Earnings Per Share | $0.51 | -- | -- | -- |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$11.69M | $68.05M | -$5.93M | -$27.1M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.